Dr Reddys Share Price Live Updates: Dr. Reddys Current Price Update
Welcome to the Dr Reddys Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...
Dr. Reddy's Laboratories outperforms competitors despite losses on the day
Dr. Reddy's Laboratories Ltd. closed 16.92% below its 52-week high of 1,420.20 rupees, which the company reached on August ...
Dr. Reddy's Lab: Near-Term Worries And Underappreciated Potential Could Lead To Huge Returns
Dr. Reddy's Lab is poised to witness crosswinds from a drop in revenue from the patent expiration of Revlimid and increased ...
Dr Reddy's Laboratories CEO: 'very positive outlook' for Indian pharma industry despite Trump 2.0
CEO of Dr Reddy's Laboratories, Erez Israeli believes his company's affordable medicines benefit the U.S. market and will be ...
Dr. Reddy's Laboratories falls Monday, underperforms market
Dr. Reddy's Laboratories Ltd. 500124 shares slipped 2.23% to 1,197.40 Indian rupees Monday, on what proved to be an ...
Dr Reddys Share Price Live Updates: Dr. Reddys shows slight decline in today's trading
Welcome to the Dr Reddys Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...
Dr Reddy's Laboratories Ltd (RDY) Q3 2025 Earnings Call Highlights: Record Revenue Growth ...
Dr Reddy's Laboratories Ltd (RDY) reports a robust 16% YoY revenue growth, driven by strategic product launches and market ...
moneycontrol.com1d
Dr Reddys Laboratories Ltd.
up 15.81% Y-o-Y Jan 28 2025 01:32 PM Hold Dr Reddys Laboratories; target of Rs 1245: KR Choksey Jan 27 2025 12:36 PM Neutral Dr Reddys Labs; target of Rs 1330: Motilal Oswal Jan 24 2025 01:19 PM ...
Barclays Reaffirms Their Buy Rating on Dr Reddy’s Laboratories (RDY)
Barclays analyst Balaji Prasad maintained a Buy rating on Dr Reddy’s Laboratories (RDY – Research Report) today and set a price target of ...
Dr. Reddy's Laboratories shares fall over 6% post subdued Q3 show; analysts divided
Dr. Reddy's shares in Friday's trade saw a sharp fall following the company's weak set of earnings for the December quarter.
Dr. Reddy’s Laboratories (RDY) Expected to Announce Earnings on Wednesday
Dr. Reddy’s Laboratories (NYSE:RDY – Get Free Report) is expected to be announcing its earnings results on Wednesday, January ...
Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Business
Dr. Reddy's Laboratories Ltd (NYSE:RDY) stock is trading lower after the company released third-quarter 2025 earnings. The pharma company clocked a net income of $165 million, marginally up from $161 ...